Pharmacological components, including 100-2000 mg formaldehyde and 10-300 mg SGLT-2 inhibitors, derivatives of which are glucose acrylonitrile phenyl, microcrystalline cellulose, polymers and croscaramelosa.

• 收藏
• 分享

专利权人:

JANSSEN PHARMACEUTICA N.V.

发明人:

LIANG YIN,RYAN JOHN,WOLDU ABRAHAM B,WU LISA E.

申请号：

CL2012000024

公开号：

CL2012000024A1

申请日:

2012.01.05

申请国别(地区):

CL

年份:

2012

代理人:

摘要：

Method for treating a disorder related to glucose and metformin which comprises administering a compound derived from beta - d-glucopyranosyl heterociclilo； Pharmaceutical composition.<；p>；Mé；todo para tratar un trastorno relacionado con la glucosa que comprende administrar metformina y un compuesto derivado de beta-D-glucopiranosil-heterociclilo； composició；n farmacé；utica.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/